NSTM NovelStem International Corp.
Retail-Retail Stores, NEC · OTC · SEC CIK 912544 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-113.6%
TTM EPS YoY-100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-1,347.4%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets6,752.9%
Debt / equity—
Current ratio0.01x
Interest coverage3.42x
Cash quality & payout
Operating cash flow / net income0.74x
Accruals ratio-352.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | — | — | — | — | — |
| SG&A expense | $32,567 | $34,935 | $4,953 | $40,748 | $39,469 | $63,964 | $94,574 | -$12,940 |
| Operating income | -$32,567 | -$34,935 | -$4,953 | -$40,748 | -$39,469 | -$63,964 | -$94,574 | -$43,035 |
| Interest expense | $51,722 | $50,860 | $36,000 | -$171,672 | $43,711 | $51,319 | $112,642 | $118,675 |
| Pretax income | -$84,289 | -$85,795 | -$55,021 | -$89,295 | -$83,180 | $2.75M | -$207,216 | -$1.79M |
| Net income | -$84,289 | -$85,795 | -$55,021 | -$89,295 | -$77,448 | $2.75M | -$207,216 | -$163,015 |
| EPS (basic) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.06 | 0.00 | — |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.06 | 0.00 | — |
| Weighted avg. shares (diluted) | 49.33M | 49.33M | 47.38M | — | 46.88M | 47.77M | 46.88M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $22,704 | $56,235 | $89,850 | $333 | $627 | $1,106 | $3,401 | $6,099 |
| Receivables | — | — | — | — | — | — | — | $10,500 |
| Current assets | $31,817 | $64,687 | $100,912 | $15,786 | $14,849 | $15,292 | $21,747 | $31,871 |
| Total assets | $31,817 | $64,687 | $100,912 | $15,786 | $14,849 | $15,292 | $149,987 | $160,111 |
| Current liabilities | $2.15M | $2.10M | — | $2.16M | — | — | — | $5.30M |
| Short-term debt | — | $1.36M | $1.33M | $1.30M | $1.26M | $1.24M | $4.16M | $4.06M |
| Total liabilities | $2.15M | $2.10M | $2.05M | $2.16M | $2.07M | $1.99M | $5.49M | $5.30M |
| Shareholders' equity | -$2.12M | -$2.03M | -$1.95M | -$2.14M | -$2.05M | -$1.97M | -$5.34M | -$5.14M |
| Shares outstanding | 49.33M | 49.33M | 49.33M | 46.88M | 46.88M | 46.88M | 46.88M | 46.88M |
| Cash flow statement | ||||||||
| Operating cash flow | -$33,531 | -$33,615 | -$138,731 | -$26,181 | -$30,959 | -$66,795 | -$43,698 | -$39,220 |
| Investing cash flow | — | — | — | — | — | — | — | $0 |
| Financing cash flow | $0 | $0 | $228,248 | $25,887 | $30,480 | $64,500 | $41,000 | $0 |
| Stock-based compensation | — | — | — | $0 | $0 | $97 | $8,741 | $8,935 |
Free plan shows the latest 8 periods; Pro shows all 37 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.